Oxford Nanopore Technologies, an innovative leader in DNA sequencing, is deepening its focus on collaboration and new development. The company has made a new strategic partnership announcement alongside the major expansion of their Compatible Products Program (CPP), which has integrated them with a new set of industry top-tier partners. The main aim of this move is to offer integrated solutions and tools to clinicians and researchers that are aligned with Oxford Nanopore’s uniquely integrated sequencing systems.
The Compatible Products Program: A Combined Attempt
In May of 2024, the CPP, or Compatible Products Programme, was started with the aim of encouraging the creation of third-party products or peripherals that complement Oxford Nanopore’s flagship technologies. The emphasis of this program is prudently defined verification and testing and streamlining processes to ensure the various compatible products from approved partners seamlessly enhance the platform, workflows, and overall experience.
New Partners, Expanded Capabilities: A Powerful Alliance
With a new set of partners, CPP has recently evolved in depth and scope because now it is comprised of a new set of organizations that bring additional specialization into the ecosystem. New partners include:
- 10x Genomics
- Agilent Technologies
- Asuragen
- Day Zero Diagnostics
- Hamilton Robotics
- New England Biolabs (NEB)
- Opentrons
- Pathosense
- Thermo Fisher Scientific
The collaboration is accentuated by a comprehensive array of single-cell and spatial biology platforms, automated sample preparation technologies, certain molecular infectious disease diagnostics, and complex molecular biology reagents, all synergistically integrated into one powerful arsenal.
These offerings facilitate and optimize the comprehensive sequencing process, including, but not limited to, the sample collection, preparation, and analysis stages, ensuring proficiency at each step.
Ensuring Compatibility: Rigorous Evaluation
All approved products from these partner companies maintain Oxford Nanopore client’s essential requirements. However, they all utilize different technologies, which means they have to go through substantial benchmark testing to ensure focus compatibility, molecular sensing, and multi-omic concordance with Oxford Nanopore.
An ecosystem yields reciprocal advantages: customers and development.
The Compatible Products Program is a remarkable partner. They aid end users in accessing Oxford Nanopore’s products while users also gain access to a continually growing community of over 125 countries. This access opens doors to new innovations and market availability.
The program offers ease of use for researchers and clinicians. Custom workflows can be constructed for individual projects, facilitated and supported by Oxford Nanopore’s information infrastructure technology, enabling swift access to vital details.
Transformational Change: A Focus on Open Innovation
Speaking at Oxford Nanopore Technologies, Thomas Bray, VP of Business Development, appreciated the effort made by the company to further open the collaborative ecosystem. He emphasized, “As the genomics domain is advancing rapidly, there is greater flexibility in how researchers and clinicians enable their workflows to advance.”
Along with “Empower broader choice and confidence” and “Expand opportunities for collaboration across scientific communities,” he stated.
A Vision of the Future: Accessible, Universal Analysis from Anywhere
This initiative is meant to strengthen and promote the broader vision of Oxford Nanopore—enable the collaborative analysis of “anything, by anyone, anywhere.” The commitment encourages researchers and others to access leading sequencing technologies to unlock barriers that hinder innovation, from sophisticated labs to remote location field-based research.
Advancing Comprehensive Collaboration in Genomics
Progress towards a more integrated, user-centric ecosystem comes with the additional Compatible Products Program from Oxford Nanopore. Bringing together leading organizations possessing complementary technologies promises to accelerate discovery in science and healthcare using advanced genomics technologies.
